The Multienzyme PDE4 Cyclic Adenosine Monophosphate–Specific Phosphodiesterase Family: Intracellular Targeting, Regulation, and Selective Inhibition by Compounds Exerting Anti-inflammatory and Antidepressant Actions
- 1 January 1998
- book chapter
- Published by Elsevier
- Vol. 44, 225-342
- https://doi.org/10.1016/s1054-3589(08)60128-3
Abstract
No abstract availableKeywords
This publication has 228 references indexed in Scilit:
- The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxideIntensive Care Medicine, 1996
- The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-α and nitric oxideInternational Journal of Immunopharmacology, 1995
- Rolipram inhibition of phosphodiesterase-4 activationEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Selective Phosphodiesterase Inhibitors in the Therapy of AsthmaClinical Immunotherapeutics, 1995
- The Crystal Structure of the N-terminal SH3 Domain of Grb2Journal of Molecular Biology, 1995
- Modulation of cellular responses by hormones: role of cAMP specific, rolipram-sensitive phosphodiesterasesMolecular and Cellular Endocrinology, 1994
- The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene familyGene, 1993
- A New Cyclic Nucleotide Phosphodiesterase Isozyme Expressed in the T-Lymphocyte Cell LinesBiochemical and Biophysical Research Communications, 1993
- Characterization of the memory gene dunce of Drosophila melanogasterJournal of Molecular Biology, 1991
- Receptor-effector coupling by G proteinsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1990